Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Lienert

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1971
[Configural frequency analysis. I. A new approach to define types and syndromes]G A Lienert
Methods of Information in Medicine|October 1, 1978
[Non-parametric evidence of homeo- and heteropoetic treatment effects in stratified cross-over designs (author's transl)]G A Lienert
Arzneimittel-Forschung|July 1, 1970
[Configuration frequency analysis of some lysergic acid diethylamide effects]G A Lienert
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1973
[Configuration frequency analysis. IV. Association structure of clinical scales and symptoms]G A Lienert
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1971
[Configural frequency analysis. 3. Two or more sample CFA tests in diagnosis and differential diagnosis]G A Lienert
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1971
[Configural frequency analysis. II. Hierarchical and agglutinating CFA in clinical psychology]G A Lienert
Der Nervenarzt|March 1, 1971
[Statistical relation of various initial symptoms in untreated cases of endogenous depression]G A Lienert, P Matussek
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1980
[Configuration frequency analysis. XI. Strategies of symptom configuration comparison before and after therapy]G A Lienert, E Straube
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1977
[Determining the effectiveness of therapeutic interventions in a time series of examination plans]G A Lienert, M Limbourg
Arzneimittel-Forschung|January 1, 1979
[Voluntary description of drug effects as a method in clinical trials. Presented using the example of pentobarbital, promazine and their combination]R Kohnen, G A Lienert
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1971
[Configural frequency analysis. I. A new approach to define types and syndromes]G A Lienert
Methods of Information in Medicine|October 1, 1978
[Non-parametric evidence of homeo- and heteropoetic treatment effects in stratified cross-over designs (author's transl)]G A Lienert
Arzneimittel-Forschung|July 1, 1970
[Configuration frequency analysis of some lysergic acid diethylamide effects]G A Lienert
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1973
[Configuration frequency analysis. IV. Association structure of clinical scales and symptoms]G A Lienert
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1971
[Configural frequency analysis. 3. Two or more sample CFA tests in diagnosis and differential diagnosis]G A Lienert
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1971
[Configural frequency analysis. II. Hierarchical and agglutinating CFA in clinical psychology]G A Lienert
Der Nervenarzt|March 1, 1971
[Statistical relation of various initial symptoms in untreated cases of endogenous depression]G A Lienert, P Matussek
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1980
[Configuration frequency analysis. XI. Strategies of symptom configuration comparison before and after therapy]G A Lienert, E Straube
Zeitschrift Fur Klinische Psychologie Und Psychotherapie|January 1, 1977
[Determining the effectiveness of therapeutic interventions in a time series of examination plans]G A Lienert, M Limbourg
Arzneimittel-Forschung|January 1, 1979
[Voluntary description of drug effects as a method in clinical trials. Presented using the example of pentobarbital, promazine and their combination]R Kohnen, G A Lienert
Pageof 6